Uses and abuses of enzyme therapy in cystic fibrosis.
作者信息
Durie P, Kalnins D, Ellis L
机构信息
Department of Gastroenterology and Nutrition, Hospital for Sick Children, Toronto, Ontario, Canada.
出版信息
J R Soc Med. 1998;91 Suppl 34(Suppl 34):2-13. doi: 10.1177/014107689809134s02.
Abstract
摘要
相似文献
1
Uses and abuses of enzyme therapy in cystic fibrosis.酶疗法在囊性纤维化中的应用与滥用
J R Soc Med. 1998;91 Suppl 34(Suppl 34):2-13. doi: 10.1177/014107689809134s02.
2
[Pancreatic enzyme substitution in patients with mucoviscidosis].
Gastroenterol J. 1990;49(4):151-5.
3
[Pancreatic infringement exocrine and endocrine in cystic fibrosis].[囊性纤维化中的胰腺外分泌和内分泌侵犯]
Arch Pediatr. 2016 Dec;23(12S):12S21-12S32. doi: 10.1016/S0929-693X(17)30059-3.
4
Pancreatic enzyme therapy and gastrointestinal symptoms in patients with cystic fibrosis.囊性纤维化患者的胰酶疗法与胃肠道症状
J Pediatr. 2005 Dec;147(6):870-1. doi: 10.1016/j.jpeds.2005.09.016.
5
[Digestive and nutritional management of adults with cystic fibrosis].[成年囊性纤维化患者的消化与营养管理]
Rev Mal Respir. 2000 Aug;17(3 Pt 2):785-97.
6
[Not Available].
Ther Umsch. 2016 Nov;73(9):500-504. doi: 10.1024/0040-5930/a000825.
7
[Pancreatic extract therapy in exocrine pancreatic insufficiency].[外分泌性胰腺功能不全的胰腺提取物疗法]
Minerva Gastroenterol Dietol. 1993 Sep;39(3):133-7.
8
Deficiency of vitamins E and A in cystic fibrosis is independent of pancreatic function and current enzyme and vitamin supplementation.囊性纤维化患者体内维生素E和维生素A缺乏与胰腺功能以及当前的酶和维生素补充无关。
Eur J Pediatr. 1996 Apr;155(4):281-5. doi: 10.1007/BF02002713.
9
[Clinical trial of several preparation types of the pancreatic extract Pancrex V in the treatment of cystic fibrosis].
Minerva Pediatr. 1985 Nov 30;37(21-22):891-6.
10
[Comparison of 2 pancreatic enzyme preparations in the treatment of digestive insufficiency in mucoviscidosis (cystic fibrosis)].[两种胰酶制剂治疗黏液黏稠症（囊性纤维化）消化功能不全的比较]
Monatsschr Kinderheilkd. 1988 Sep;136(9):626-9.
引用本文的文献
1
The Regulatory Role of Pancreatic Enzymes in the Maintenance of Small Intestinal Structure and Enterocyte Turnover with Special Reference to Alpha Amylase.胰腺酶在维持小肠结构和肠上皮细胞更新中的调节作用，特别提及α淀粉酶
Int J Mol Sci. 2024 Dec 30;26(1):249. doi: 10.3390/ijms26010249.
2
Validation of an omega-3 substrate challenge absorption test as an indicator of global fat lipolysis.验证 omega-3 底物挑战吸收试验作为全身脂肪脂解的指标。
PLoS One. 2023 May 8;18(5):e0284651. doi: 10.1371/journal.pone.0284651. eCollection 2023.
3
The road for survival improvement of cystic fibrosis patients in Arab countries.阿拉伯国家囊性纤维化患者生存改善之路。
Int J Pediatr Adolesc Med. 2015 Jun;2(2):47-58. doi: 10.1016/j.ijpam.2015.05.006. Epub 2015 Jun 19.
4
Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis.评估囊性纤维化患者胰酶替代疗法疗效和安全性的研究设计考量
Clin Investig (Lond). 2013 Aug;3(8):731-741. doi: 10.4155/cli.13.63.
5
Maintenance of nutritional status in patients with cystic fibrosis: new and emerging therapies.囊性纤维化患者营养状况的维持：新出现的治疗方法
Drug Des Devel Ther. 2012;6:151-61. doi: 10.2147/DDDT.S9258. Epub 2012 Jun 20.
6
An activated immune and inflammatory response targets the pancreas of newborn pigs with cystic fibrosis.激活的免疫和炎症反应靶向患有囊性纤维化的新生仔猪的胰腺。
Pancreatology. 2011;11(5):506-15. doi: 10.1159/000332582. Epub 2011 Nov 1.
7
Control of malabsorption in cystic fibrosis.囊性纤维化中吸收不良的控制
Paediatr Drugs. 2000 May-Jun;2(3):205-22. doi: 10.2165/00128072-200002030-00005.
本文引用的文献
1
Pancreatic exocrine function in neoplastic and inflammatory disease; a simple and reliable new test.肿瘤性和炎性疾病中的胰腺外分泌功能；一种简单可靠的新检测方法。
Gastroenterology. 1962 Mar;42:275-80.
2
13Carbon mixed triglyceride breath test and pancreatic enzyme supplementation in cystic fibrosis.13碳混合甘油三酯呼气试验与囊性纤维化患者的胰酶补充治疗
Arch Dis Child. 1997 Apr;76(4):349-51. doi: 10.1136/adc.76.4.349.
3
High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.高剂量胰酶补充剂与囊性纤维化患儿的纤维性结肠病
N Engl J Med. 1997 May 1;336(18):1283-9. doi: 10.1056/NEJM199705013361803.
4
Sensitivity and specificity of quantitative determination of pancreatic elastase 1 in feces of children.
J Pediatr Gastroenterol Nutr. 1997 Jan;24(1):53-5. doi: 10.1097/00005176-199701000-00013.
5
High- versus low-lipase acid-resistant enzyme preparations in cystic fibrosis: a crossover randomized clinical trial.囊性纤维化中高与低脂肪酶耐酸酶制剂的比较：一项交叉随机临床试验。
J Pediatr Gastroenterol Nutr. 1996 Jan;22(1):73-8. doi: 10.1097/00005176-199601000-00012.
6
Immunoreactive elastase I: clinical evaluation of a new noninvasive test of pancreatic function.免疫反应性弹性蛋白酶I：胰腺功能新无创检测的临床评估
Clin Chem. 1996 Feb;42(2):222-6.
7
Stated versus actual lipase activity in pancreatic enzyme supplements: implications for clinical use.胰酶补充剂中宣称的与实际的脂肪酶活性：对临床应用的影响。
J Pediatr Gastroenterol Nutr. 1995 Jul;21(1):59-63. doi: 10.1097/00005176-199507000-00010.
8
Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations.囊性纤维化患者胰酶的临床药理学及微囊化制剂的体外性能
J Clin Pharmacol. 1994 Feb;34(2):158-66. doi: 10.1002/j.1552-4604.1994.tb03981.x.
9
Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes.囊性纤维化和高强度胰酶患者的升结肠狭窄
Lancet. 1994 Jan 8;343(8889):85-6. doi: 10.1016/s0140-6736(94)90817-6.
10
Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients.
Aliment Pharmacol Ther. 1994 Dec;8(6):603-7. doi: 10.1111/j.1365-2036.1994.tb00337.x.
Zotero 插件